Epstein-Barr virus vaccine (Admedus Vaccines)

N/A

Report date: 2026/01/22 16:42:14

Base Information

Drug NameEpstein-Barr virus vaccine (Admedus Vaccines)
Drug Alias NameEBV vaccine (Coridon)EBV vaccine (University of Queensland)Epstein-Barr virus vaccine (University of Queensland)Epstein-Barr virus vaccine (Coridon)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfectious MononucleosisEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdmedusThe University Of Queensland
Active IndicationsN/A
Inactive IndicationsInfectious MononucleosisEpstein-Barr Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A